2019
DOI: 10.1002/ccr3.1909
|View full text |Cite
|
Sign up to set email alerts
|

Urothelial neoplasm in a 19‐year‐old male patient with urine discoloration, negative lab, and imaging workup: Should we investigate the findings or the symptom?

Abstract: Key Clinical Message With few cases of PUNLMPs in young adults being reported in the literature, we hope to raise clinical awareness of prompt and effective diagnosis, while maintaining a high index of suspicion among health professionals. Even in the absence of red blood cells in the urine and subsequent negative imaging workup, clinicians should not delay performance of diagnostic cystoscopy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…This underscores the necessity of staying vigilant for catheterization-related complications. This vigilance is crucial because usually, no further tests are performed to confirm proper positioning, leading to frequent oversight of urologic complications [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…This underscores the necessity of staying vigilant for catheterization-related complications. This vigilance is crucial because usually, no further tests are performed to confirm proper positioning, leading to frequent oversight of urologic complications [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Oncocytomas should be included in the differential diagnosis of patients with renal mass regardless of their size. A high index of clinical suspicion and awareness is paramount to prompt and effective investigation, even in cases of patient-reported symptoms [ 7 ]. Because it is not possible to differentiate oncocytomas from renal cell carcinomas based on clinical, radiologic, or laboratory criteria, management may be challenging.…”
Section: Discussionmentioning
confidence: 99%
“…Neoadjuvant regimens usually used were GC (cisplatin/gemcitabine), AI (Adriamycin/ifosfamide), and MVAC (methotrexate/vinblastine/Adriamycin/cisplatin). However, we can't conclude the benefit of neoadjuvant treatment because of the rarity of cases [ 8 ].…”
Section: Discussionmentioning
confidence: 99%